EBS 8-K 2026-01-12

Emergent BioSolutions Inc. (EBS) 8-K dated 2026-01-12 — accession 0001367644-26-000003. This URL is the filing, not the EBS hub.

Emergent BioSolutions Inc. (EBS) is a drug manufacturers - specialty & generic company listed on US.

Emergent BioSolutions Inc. filed a 8-K on 2026-01-12. Accession 0001367644-26-000003.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported EBS revenue for 2025-12-31 was $742.9M. Net income was $52.6M. EBS currently screens at market cap $416.4M.

Not investment advice. The EBS SEC hub lists recent forms. The stock page is the research view.